您的位置: 首页 > 农业专利 > 详情页

The CCR5 for the treatment of cancer is used for using regulator
专利权人:
PROSTAGENE LLC
发明人:
PESTELL, RICHARD, G.
申请号:
EP13790117
公开号:
EP2861302A4
申请日:
2013.05.14
申请国别(地区):
EP
年份:
2016
代理人:
摘要:
The disclosure is partly guided to a kind of method for being used to determine whether that there is a main body of cancer to be among risk for the developing transfer of cancer. In one embodiment, method includes (a) obtaining a biological sample from the main body with cancer (b) CCR5 cooperation bases at least one CCR5 expressions and/or expression in the biological sample is determined If (c) compared in CCR5 cooperation bases at least one the CCR5 expressions and/or expression in a control sample, at least one expression of CCR5 and/or CCR5 determining in step (b) cooperations base increases, so for the developing transfer of cancer, main body is accredited as possible be in danger.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充